Skip to Main Content
Our Commitment to Diversity


Whitney J. Smith

Series A financing and corporate ostructuring and governance advice for a Canadian company with operations in Uruguay and the first government license to grow and export medical cannabis in Uruguay
Acquisition of Lighting Technologies International, a specialty lighting company
Acquisition of Digital Lifestyle Outfitters, an electronics peripherals and accessories distribution company
Acquisition of Ethic Bio Lab, a clinical trials business
Acquisition of a basket of 14 products in an FTC-mandated divestiture related to Watson Pharmaceuticals’ acquisition of Actavis
Acquisition of six branded foam dermatology products from GSK
Acquisition of 42 generic products in an FTC-mandated divestiture related to Teva’s acquisition of Allergan’s generic pharmaceutical business
Divestiture of multiple offices and insurance brokerage businesses
Management buyout of PE porfolio company and subsequent restructuring involving an equity investment by TPG, a tax-exempt bond offering, a credit facility and a real estate purchase for the purpose of constructing and commissioning a biosolids-to-fertilizer plant
Divestiture of Solvay’s formulated resins business
Acquisition of Somerset Therapeutics, a sterile injectible business, and its affiliate Wintac Limited, a Bangalore, India-based CDMO listed on the Bombay Stock Exchange (pending regulatory approval)
Acquisition of Nuray Chemicals Private Limited, an India-based developer and manufacturer of API
Acquisition of Balihoo, a provider of digital advertising technology enabling national brands to execute hyper-local campaigns
Acquisition of, a demand-side digital advertising technology company
Acquisition of bRealTime, a supply-side digital advertising technology company that helps publishers monetize inventory through real-time bidding exchanges
Acquisition of, a publicly traded U.S. broker-dealer
Acquisition of Raytel Medical Corporation, a U.S. remote cardiac monitoring company from an Israeli telemedicine company
Sale of Par Pharmaceutical's Charlotte, North Carolina and Huntsville, Alabama manufacturing facilities
Advised NYSE-listed company in connection with a significant restatement of past financial statements and related SEC and NYSE inquiries
Acquisition of Edict Pharmaceuticals, an India-based R&D company
Acquisition of Innoteq, a developer and manufacturer of transdermal patch and thin film pharmaceutical products
Advised a publicly traded company and its Board of Directors in connection with an unsolicited proposal to merge the company and subsequently in connection with negotiations with an activist hedge fund that had acquired a 10% stake in the company
Acquisition of Westlock Controls, a manufacturer of switchboxes, position transmitters and other solutions for networking, monitoring and controlling process valves
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel